EMA Authorised: Aldara (imiquimod) — Viatris Healthcare Limited

View source ↗

Summary

The European Medicines Agency authorised Aldara (imiquimod) for multiple indications under Viatris Healthcare Limited, including genital warts, actinic keratosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Basal Cell Carcinoma
• Genital Warts

Drugs mentioned

• Aldara (imiquimod)

Snippet

Status: Authorised. Therapeutic area: Condylomata Acuminata;Keratosis;Keratosis, Actinic;Carcinoma, Basal Cell. MAH: Viatris Healthcare Limited. Decision date: 17/07/2025